Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | MMP3 | P08254 | 2/20 | 0.42 |
| ▸ | MMP9 | P14780 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TLR2 | O60603 | 1/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL19837752 | 0.96 | TSHR (0.54) | TSHRALDH1A1TDP1SMN1; SMN2MMP3 | |
| Sulfuric Acid SCHEMBL1818768 | 0.96 | TSHR (0.54) | TSHRALDH1A1TDP1SMN1; SMN2MMP3 | |
| Sulfuric Acid SCHEMBL29684494 | 0.96 | TSHR (0.54) | TSHRALDH1A1TDP1SMN1; SMN2MMP3 | |
| Sulfuric Acid SCHEMBL19900361 | 0.96 | TSHR (0.54) | TSHRALDH1A1TDP1SMN1; SMN2MMP3 | |
| Sulfuric Acid SCHEMBL1815849 | 0.96 | TSHR (0.54) | TSHRALDH1A1TDP1SMN1; SMN2MMP3 | |
| SCHEMBL1819631 | 0.96 | TSHR (0.54) | TSHRALDH1A1TDP1SMN1; SMN2MMP3 | |
| Sulfuric Acid SCHEMBL31198220 | 0.96 | TSHR (0.54) | TSHRALDH1A1TDP1SMN1; SMN2MMP3 | |
| SCHEMBL1818338 | 0.96 | TSHR (0.54) | TSHRALDH1A1TDP1SMN1; SMN2MMP3 | |
| SCHEMBL1723696 | 0.94 | TSHR (0.59) | TSHRALDH1A1TDP1MMP3MMP9 | |
| SCHEMBL1723878 | 0.94 | TSHR (0.59) | TSHRALDH1A1TDP1MMP3MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104995180-A | Crystalline forms of neurotrophin mimetic compounds and their salts | PHARMATROPHIX INC | 2015-10-21 | — | — | CN | claimed |
| CN-102740856-B | Crystalline forms of neurotrophin mimetic compounds and salts thereof | PHARMATROPHIX INC | 2015-02-18 | — | — | CN | claimed |
| CN-102740856-A | Crystalline forms of neurotrophin mimetic compounds and salts thereof | PHARMATROPHIX INC | 2012-10-17 | — | — | CN | claimed |
| CN-108383804-A | The crystal form of neurotrophin simulated compound and its salt | 特罗菲克斯制药股份有限公司 | 2018-08-10 | — | — | CN | disclosed |
| CN-104761515-B | The crystal formation of neurotrophin simulated compound and its salt | 特罗菲克斯制药股份有限公司 | 2018-03-09 | — | — | CN | disclosed |
| CN-104995180-A | Crystalline forms of neurotrophin mimetic compounds and their salts | PHARMATROPHIX INC | 2015-10-21 | — | — | CN | disclosed |
| CN-104761515-A | Crystalline forms of neurotrophin mimetic compounds and salts of same | PHARMATROPHIX INC | 2015-07-08 | — | — | CN | disclosed |
| CN-102740856-B | Crystalline forms of neurotrophin mimetic compounds and salts thereof | PHARMATROPHIX INC | 2015-02-18 | — | — | CN | disclosed |
| CN-102740856-A | Crystalline forms of neurotrophin mimetic compounds and salts thereof | PHARMATROPHIX INC | 2012-10-17 | — | — | CN | disclosed |